Flws/1 (FLWS) Holder Northpointe Capital Has Decreased Holding by $4.36 Million as Share Value Rose; Argyle Capital Management Stake in Cvs Health (CVS) Increased as Shares Declined

May 18, 2018 - By Peter Erickson

CVS Health Corporation (NYSE:CVS) Logo

Argyle Capital Management Inc increased its stake in Cvs Health Corp (CVS) by 54.18% based on its latest 2017Q4 regulatory filing with the SEC. Argyle Capital Management Inc bought 13,550 shares as the company’s stock declined 17.45% with the market. The institutional investor held 38,560 shares of the medical and nursing services company at the end of 2017Q4, valued at $2.80 million, up from 25,010 at the end of the previous reported quarter. Argyle Capital Management Inc who had been investing in Cvs Health Corp for a number of months, seems to be bullish on the $66.86 billion market cap company. The stock decreased 0.56% or $0.37 during the last trading session, reaching $65.76. About 6.61 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 18, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Northpointe Capital Llc decreased its stake in Flws/1 (FLWS) by 38.78% based on its latest 2017Q4 regulatory filing with the SEC. Northpointe Capital Llc sold 436,131 shares as the company’s stock rose 4.85% while stock markets declined. The institutional investor held 688,445 shares of the consumer services company at the end of 2017Q4, valued at $7.37 million, down from 1.12 million at the end of the previous reported quarter. Northpointe Capital Llc who had been investing in Flws/1 for a number of months, seems to be less bullish one the $800.26 million market cap company. The stock increased 1.64% or $0.2 during the last trading session, reaching $12.4. About 221,142 shares traded or 5.58% up from the average. 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) has risen 17.82% since May 18, 2017 and is uptrending. It has outperformed by 6.27% the S&P500.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It worsened, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Dimensional Fund Advsr Limited Partnership reported 0.33% in CVS Health Corporation (NYSE:CVS). Hillsdale Invest Mgmt has invested 0.07% in CVS Health Corporation (NYSE:CVS). Twin Cap Mgmt Inc owns 112,240 shares. Psagot Inv House invested in 0.2% or 64,832 shares. Smith Moore & has 0.14% invested in CVS Health Corporation (NYSE:CVS) for 7,083 shares. 13,296 are owned by Beck Mack And Oliver Ltd Liability Corp. Roanoke Asset Mgmt Corporation owns 25,432 shares for 0.88% of their portfolio. Seaward Mngmt Partnership holds 0.41% or 121,129 shares. 38,691 are owned by First Personal Fincl. M&R Cap Mgmt, New York-based fund reported 61,354 shares. New York-based Spark Invest Ltd Liability Corporation has invested 0.11% in CVS Health Corporation (NYSE:CVS). Proffitt And Goodson Inc stated it has 0.44% of its portfolio in CVS Health Corporation (NYSE:CVS). Loudon Inv Management Limited Liability reported 8,303 shares. Crawford Counsel reported 669,639 shares. Northwestern Mutual Wealth Communication holds 0.09% or 191,723 shares.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” on April 26, 2018, also 247Wallst.com with their article: “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” published on April 29, 2018, Seekingalpha.com published: “We Are Playing The CVS Hand” on May 11, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Nasdaq.com and their article: “3 Top Stocks With High Dividend Yields” published on May 15, 2018 as well as Seekingalpha.com‘s news article titled: “CVS: Going Long, And Understanding The Aetna Deal” with publication date: April 30, 2018.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. On Tuesday, November 21 the stock rating was maintained by Leerink Swann with “Buy”. The firm has “Hold” rating by Jefferies given on Wednesday, October 18. The stock has “Outperform” rating by Leerink Swann on Friday, February 9. On Monday, December 4 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by Jefferies with “Hold” on Tuesday, November 7. On Friday, November 10 the stock rating was upgraded by Needham to “Buy”. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Thursday, January 4 by Robert W. Baird. Deutsche Bank maintained CVS Health Corporation (NYSE:CVS) rating on Thursday, August 20. Deutsche Bank has “Hold” rating and $121 target. The firm has “Buy” rating by SunTrust given on Thursday, January 4. The company was maintained on Friday, October 13 by SunTrust.

Since February 16, 2018, it had 2 buys, and 1 insider sale for $713,454 activity. Foulkes Helena had sold 19,965 shares worth $1.42 million on Friday, February 16. Shares for $619,900 were bought by BROWN C DAVID II.

Northpointe Capital Llc, which manages about $1.18B and $892.52M US Long portfolio, upped its stake in Exxon Mobil Corp (NYSE:XOM) by 10,939 shares to 124,107 shares, valued at $10.38 million in 2017Q4, according to the filing. It also increased its holding in Phillips 66 (NYSE:PSX) by 11,337 shares in the quarter, for a total of 46,543 shares, and has risen its stake in Express Scripts Hldg Co (NASDAQ:ESRX).

Since February 15, 2018, it had 0 buys, and 8 insider sales for $1.50 million activity. CANNAVINO JAMES A sold $127,452 worth of 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) on Friday, February 16. $192,900 worth of stock was sold by MCCANN CHRISTOPHER G on Monday, April 16.

Investors sentiment increased to 2.21 in 2017 Q4. Its up 1.14, from 1.07 in 2017Q3. It increased, as 8 investors sold FLWS shares while 21 reduced holdings. 25 funds opened positions while 39 raised stakes. 20.46 million shares or 1.08% more from 20.24 million shares in 2017Q3 were reported. Schwab Charles Management reported 129,255 shares stake. Moreover, Legal And General Gp Public Ltd Company has 0% invested in 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) for 6,952 shares. Northern Tru reported 329,371 shares stake. The California-based Parallax Volatility Advisers Lp has invested 0% in 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS). Teton Advsr Inc, New York-based fund reported 523,846 shares. Pnc Financial Serv Grp Incorporated reported 0% stake. Stone Ridge Asset Mgmt Limited Co reported 71,699 shares or 0.05% of all its holdings. Moreover, Fdx has 0.01% invested in 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) for 31,991 shares. Eagle Boston Inv reported 1.6% in 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS). Vanguard Group has invested 0% in 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS). 10,024 are held by Credit Suisse Ag. Balyasny Asset Management Limited Liability Company, Illinois-based fund reported 27,083 shares. Sei Invs has 297,967 shares. Gabelli Funds Limited Liability accumulated 0.02% or 270,000 shares. Manufacturers Life The stated it has 22,947 shares.

Analysts await 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) to report earnings on August, 23. They expect $-0.12 EPS, down 9.09% or $0.01 from last year’s $-0.11 per share. After $-0.13 actual EPS reported by 1-800-FLOWERS.COM, Inc. for the previous quarter, Wall Street now forecasts -7.69% EPS growth.

More news for 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) were recently published by: Benzinga.com, which released: “1-800 Flowers Q3 Earnings Preview” on April 30, 2018. Nasdaq.com‘s article titled: “1-800 Flowers President & CEO Chris McCann interviewed by Advisor Access” and published on May 08, 2018 is yet another important article.

Among 8 analysts covering 1-800-Flowers.Com (NASDAQ:FLWS), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. 1-800-Flowers.Com had 19 analyst reports since August 31, 2015 according to SRatingsIntel. The stock of 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) has “Buy” rating given on Thursday, February 1 by Noble Financial. B. Riley & Co maintained the shares of FLWS in report on Thursday, November 3 with “Buy” rating. The company was maintained on Thursday, December 28 by Noble Financial. The company was maintained on Wednesday, August 23 by Benchmark. The stock has “Outperform” rating by Ladenburg Thalmann on Wednesday, August 17. Noble Financial maintained the stock with “Buy” rating in Wednesday, November 1 report. Northcoast downgraded the shares of FLWS in report on Tuesday, December 26 to “Neutral” rating. The stock of 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) earned “Neutral” rating by DA Davidson on Wednesday, May 2. Wunderlich initiated the stock with “Buy” rating in Thursday, January 21 report. The stock has “Buy” rating by Benchmark on Wednesday, May 2.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.